ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EZH2
|
ENSG00000106462.6 | EZH2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EZH2 | hg19_v2_chr7_-_148581251_148581347 | -0.52 | 3.7e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51456344 | 5.41 |
ENST00000336334.3 ENST00000593428.1 |
KLK5 |
kallikrein-related peptidase 5 |
chr7_-_41740181 | 3.87 |
ENST00000442711.1 |
INHBA |
inhibin, beta A |
chr1_+_86889769 | 3.29 |
ENST00000370565.4 |
CLCA2 |
chloride channel accessory 2 |
chr12_+_66217911 | 3.26 |
ENST00000403681.2 |
HMGA2 |
high mobility group AT-hook 2 |
chr1_-_209824643 | 3.24 |
ENST00000391911.1 ENST00000415782.1 |
LAMB3 |
laminin, beta 3 |
chr6_-_134639180 | 3.20 |
ENST00000367858.5 |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
chr8_-_41166953 | 2.74 |
ENST00000220772.3 |
SFRP1 |
secreted frizzled-related protein 1 |
chr10_-_105845674 | 2.74 |
ENST00000353479.5 ENST00000369733.3 |
COL17A1 |
collagen, type XVII, alpha 1 |
chr14_-_67859422 | 2.62 |
ENST00000556532.1 |
PLEK2 |
pleckstrin 2 |
chr12_-_6484376 | 2.28 |
ENST00000360168.3 ENST00000358945.3 |
SCNN1A |
sodium channel, non-voltage-gated 1 alpha subunit |
chr1_-_153588765 | 2.16 |
ENST00000368701.1 ENST00000344616.2 |
S100A14 |
S100 calcium binding protein A14 |
chr19_-_51456321 | 2.07 |
ENST00000391809.2 |
KLK5 |
kallikrein-related peptidase 5 |
chr11_-_62521614 | 2.07 |
ENST00000527994.1 ENST00000394807.3 |
ZBTB3 |
zinc finger and BTB domain containing 3 |
chr2_-_113594279 | 2.00 |
ENST00000416750.1 ENST00000418817.1 ENST00000263341.2 |
IL1B |
interleukin 1, beta |
chr19_+_35606692 | 1.99 |
ENST00000406242.3 ENST00000454903.2 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr1_-_153588334 | 1.85 |
ENST00000476873.1 |
S100A14 |
S100 calcium binding protein A14 |
chr15_+_43885252 | 1.79 |
ENST00000453782.1 ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B |
creatine kinase, mitochondrial 1B |
chr14_-_105420241 | 1.76 |
ENST00000557457.1 |
AHNAK2 |
AHNAK nucleoprotein 2 |
chr4_+_30721968 | 1.76 |
ENST00000361762.2 |
PCDH7 |
protocadherin 7 |
chr1_-_68698222 | 1.75 |
ENST00000370976.3 ENST00000354777.2 ENST00000262348.4 ENST00000540432.1 |
WLS |
wntless Wnt ligand secretion mediator |
chr12_-_6484715 | 1.75 |
ENST00000228916.2 |
SCNN1A |
sodium channel, non-voltage-gated 1 alpha subunit |
chr18_+_47088401 | 1.74 |
ENST00000261292.4 ENST00000427224.2 ENST00000580036.1 |
LIPG |
lipase, endothelial |
chr6_+_146864829 | 1.67 |
ENST00000367495.3 |
RAB32 |
RAB32, member RAS oncogene family |
chr17_-_40575535 | 1.66 |
ENST00000357037.5 |
PTRF |
polymerase I and transcript release factor |
chr15_+_43985084 | 1.63 |
ENST00000434505.1 ENST00000411750.1 |
CKMT1A |
creatine kinase, mitochondrial 1A |
chr22_-_36236623 | 1.51 |
ENST00000405409.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr4_+_74735102 | 1.48 |
ENST00000395761.3 |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr22_-_36236265 | 1.44 |
ENST00000414461.2 ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr12_-_53009116 | 1.41 |
ENST00000552855.1 |
KRT73 |
keratin 73 |
chr5_+_92919043 | 1.41 |
ENST00000327111.3 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
chr15_+_43886057 | 1.39 |
ENST00000441322.1 ENST00000413657.2 ENST00000453733.1 |
CKMT1B |
creatine kinase, mitochondrial 1B |
chr4_-_16900242 | 1.38 |
ENST00000502640.1 ENST00000506732.1 |
LDB2 |
LIM domain binding 2 |
chr19_-_4338783 | 1.33 |
ENST00000601482.1 ENST00000600324.1 |
STAP2 |
signal transducing adaptor family member 2 |
chr9_+_75766652 | 1.29 |
ENST00000257497.6 |
ANXA1 |
annexin A1 |
chr19_+_35607166 | 1.25 |
ENST00000604255.1 ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr6_-_10415218 | 1.22 |
ENST00000466073.1 ENST00000498450.1 |
TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr6_-_56507586 | 1.21 |
ENST00000439203.1 ENST00000518935.1 ENST00000446842.2 ENST00000370765.6 ENST00000244364.6 |
DST |
dystonin |
chr19_-_51522955 | 1.18 |
ENST00000358789.3 |
KLK10 |
kallikrein-related peptidase 10 |
chr4_-_16900217 | 1.16 |
ENST00000441778.2 |
LDB2 |
LIM domain binding 2 |
chr19_-_51504852 | 1.15 |
ENST00000391806.2 ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8 |
kallikrein-related peptidase 8 |
chr17_+_48133459 | 1.15 |
ENST00000320031.8 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
chr4_-_16900184 | 1.15 |
ENST00000515064.1 |
LDB2 |
LIM domain binding 2 |
chr11_-_119993734 | 1.14 |
ENST00000533302.1 |
TRIM29 |
tripartite motif containing 29 |
chr5_-_73937244 | 1.13 |
ENST00000302351.4 ENST00000510316.1 ENST00000508331.1 |
ENC1 |
ectodermal-neural cortex 1 (with BTB domain) |
chr1_-_150780757 | 1.13 |
ENST00000271651.3 |
CTSK |
cathepsin K |
chr3_+_193853927 | 1.12 |
ENST00000232424.3 |
HES1 |
hes family bHLH transcription factor 1 |
chr8_-_49834299 | 1.10 |
ENST00000396822.1 |
SNAI2 |
snail family zinc finger 2 |
chr19_+_39138320 | 1.10 |
ENST00000424234.2 ENST00000390009.3 ENST00000589528.1 |
ACTN4 |
actinin, alpha 4 |
chr18_+_29027696 | 1.09 |
ENST00000257189.4 |
DSG3 |
desmoglein 3 |
chr2_-_24308051 | 1.08 |
ENST00000238721.4 ENST00000335934.4 |
TP53I3 |
tumor protein p53 inducible protein 3 |
chr8_+_102504651 | 1.04 |
ENST00000251808.3 ENST00000521085.1 |
GRHL2 |
grainyhead-like 2 (Drosophila) |
chrX_+_102631248 | 1.04 |
ENST00000361298.4 ENST00000372645.3 ENST00000372635.1 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr15_+_43985725 | 1.04 |
ENST00000413453.2 |
CKMT1A |
creatine kinase, mitochondrial 1A |
chr1_-_68698197 | 1.02 |
ENST00000370973.2 ENST00000370971.1 |
WLS |
wntless Wnt ligand secretion mediator |
chr1_+_81771806 | 1.01 |
ENST00000370721.1 ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2 |
latrophilin 2 |
chr6_+_53659746 | 1.01 |
ENST00000370888.1 |
LRRC1 |
leucine rich repeat containing 1 |
chr1_+_186798073 | 1.00 |
ENST00000367466.3 ENST00000442353.2 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
chr1_-_153599426 | 0.99 |
ENST00000392622.1 |
S100A13 |
S100 calcium binding protein A13 |
chr16_+_31483451 | 0.99 |
ENST00000565360.1 ENST00000361773.3 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
chr1_+_152881014 | 0.98 |
ENST00000368764.3 ENST00000392667.2 |
IVL |
involucrin |
chr4_-_16900410 | 0.98 |
ENST00000304523.5 |
LDB2 |
LIM domain binding 2 |
chr9_-_14314566 | 0.97 |
ENST00000397579.2 |
NFIB |
nuclear factor I/B |
chr3_-_99569821 | 0.97 |
ENST00000487087.1 |
FILIP1L |
filamin A interacting protein 1-like |
chr6_+_106959718 | 0.96 |
ENST00000369066.3 |
AIM1 |
absent in melanoma 1 |
chr2_-_55277654 | 0.94 |
ENST00000337526.6 ENST00000317610.7 ENST00000357732.4 |
RTN4 |
reticulon 4 |
chr2_-_165424973 | 0.91 |
ENST00000543549.1 |
GRB14 |
growth factor receptor-bound protein 14 |
chr16_+_69221028 | 0.91 |
ENST00000336278.4 |
SNTB2 |
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr2_+_234668894 | 0.91 |
ENST00000305208.5 ENST00000608383.1 ENST00000360418.3 |
UGT1A8 UGT1A1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr7_+_134576317 | 0.89 |
ENST00000424922.1 ENST00000495522.1 |
CALD1 |
caldesmon 1 |
chr2_-_55277692 | 0.89 |
ENST00000394611.2 |
RTN4 |
reticulon 4 |
chr18_+_3449695 | 0.87 |
ENST00000343820.5 |
TGIF1 |
TGFB-induced factor homeobox 1 |
chr11_-_104905840 | 0.86 |
ENST00000526568.1 ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
chr9_+_124062071 | 0.86 |
ENST00000373818.4 |
GSN |
gelsolin |
chr12_-_115121962 | 0.86 |
ENST00000349155.2 |
TBX3 |
T-box 3 |
chr10_+_17272608 | 0.85 |
ENST00000421459.2 |
VIM |
vimentin |
chr12_+_79258444 | 0.85 |
ENST00000261205.4 |
SYT1 |
synaptotagmin I |
chr13_-_72441315 | 0.85 |
ENST00000305425.4 ENST00000313174.7 ENST00000354591.4 |
DACH1 |
dachshund homolog 1 (Drosophila) |
chr6_+_142623063 | 0.85 |
ENST00000296932.8 ENST00000367609.3 |
GPR126 |
G protein-coupled receptor 126 |
chr3_+_158991025 | 0.84 |
ENST00000337808.6 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
chr10_+_75670862 | 0.83 |
ENST00000446342.1 ENST00000372764.3 ENST00000372762.4 |
PLAU |
plasminogen activator, urokinase |
chr18_+_3449821 | 0.83 |
ENST00000407501.2 ENST00000405385.3 ENST00000546979.1 |
TGIF1 |
TGFB-induced factor homeobox 1 |
chr4_-_101439148 | 0.83 |
ENST00000511970.1 ENST00000502569.1 ENST00000305864.3 |
EMCN |
endomucin |
chr12_+_79258547 | 0.82 |
ENST00000457153.2 |
SYT1 |
synaptotagmin I |
chr9_-_14314518 | 0.82 |
ENST00000397581.2 |
NFIB |
nuclear factor I/B |
chr10_-_33623564 | 0.81 |
ENST00000374875.1 ENST00000374822.4 |
NRP1 |
neuropilin 1 |
chr1_+_156052354 | 0.81 |
ENST00000368301.2 |
LMNA |
lamin A/C |
chr8_-_49833978 | 0.80 |
ENST00000020945.1 |
SNAI2 |
snail family zinc finger 2 |
chr15_+_63335899 | 0.79 |
ENST00000561266.1 |
TPM1 |
tropomyosin 1 (alpha) |
chr2_-_31637560 | 0.79 |
ENST00000379416.3 |
XDH |
xanthine dehydrogenase |
chr13_-_80915059 | 0.79 |
ENST00000377104.3 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
chr12_-_28125638 | 0.78 |
ENST00000545234.1 |
PTHLH |
parathyroid hormone-like hormone |
chr2_+_33172221 | 0.77 |
ENST00000354476.3 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
chr6_+_12290586 | 0.77 |
ENST00000379375.5 |
EDN1 |
endothelin 1 |
chr10_+_114709999 | 0.77 |
ENST00000355995.4 ENST00000545257.1 ENST00000543371.1 ENST00000536810.1 ENST00000355717.4 ENST00000538897.1 ENST00000534894.1 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr6_+_86159821 | 0.77 |
ENST00000369651.3 |
NT5E |
5'-nucleotidase, ecto (CD73) |
chr3_-_9291063 | 0.77 |
ENST00000383836.3 |
SRGAP3 |
SLIT-ROBO Rho GTPase activating protein 3 |
chr9_-_107690420 | 0.77 |
ENST00000423487.2 ENST00000374733.1 ENST00000374736.3 |
ABCA1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
chr16_+_31483374 | 0.75 |
ENST00000394863.3 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
chr14_-_65409438 | 0.74 |
ENST00000557049.1 |
GPX2 |
glutathione peroxidase 2 (gastrointestinal) |
chr17_+_32582293 | 0.72 |
ENST00000580907.1 ENST00000225831.4 |
CCL2 |
chemokine (C-C motif) ligand 2 |
chr6_-_110501200 | 0.72 |
ENST00000392586.1 ENST00000419252.1 ENST00000392589.1 ENST00000392588.1 ENST00000359451.2 |
WASF1 |
WAS protein family, member 1 |
chrX_-_153141302 | 0.71 |
ENST00000361699.4 ENST00000543994.1 ENST00000370057.3 ENST00000538883.1 ENST00000361981.3 |
L1CAM |
L1 cell adhesion molecule |
chr6_-_110500905 | 0.71 |
ENST00000392587.2 |
WASF1 |
WAS protein family, member 1 |
chr8_-_18666360 | 0.71 |
ENST00000286485.8 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
chr19_-_4338838 | 0.70 |
ENST00000594605.1 |
STAP2 |
signal transducing adaptor family member 2 |
chr5_+_96079240 | 0.69 |
ENST00000515663.1 |
CAST |
calpastatin |
chr1_-_154943002 | 0.68 |
ENST00000606391.1 |
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
chr5_+_102201509 | 0.68 |
ENST00000348126.2 ENST00000379787.4 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
chr8_-_42065075 | 0.68 |
ENST00000429089.2 ENST00000519510.1 ENST00000429710.2 ENST00000524009.1 |
PLAT |
plasminogen activator, tissue |
chr11_+_19799327 | 0.68 |
ENST00000540292.1 |
NAV2 |
neuron navigator 2 |
chr1_-_147245484 | 0.67 |
ENST00000271348.2 |
GJA5 |
gap junction protein, alpha 5, 40kDa |
chr1_-_163172625 | 0.66 |
ENST00000527988.1 ENST00000531476.1 ENST00000530507.1 |
RGS5 |
regulator of G-protein signaling 5 |
chr8_-_6420777 | 0.66 |
ENST00000415216.1 |
ANGPT2 |
angiopoietin 2 |
chr9_+_71820057 | 0.65 |
ENST00000539225.1 |
TJP2 |
tight junction protein 2 |
chrX_+_105969893 | 0.65 |
ENST00000255499.2 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
chr3_+_189507432 | 0.65 |
ENST00000354600.5 |
TP63 |
tumor protein p63 |
chr16_+_54964740 | 0.65 |
ENST00000394636.4 |
IRX5 |
iroquois homeobox 5 |
chr4_-_101439242 | 0.64 |
ENST00000296420.4 |
EMCN |
endomucin |
chr14_-_99737565 | 0.64 |
ENST00000357195.3 |
BCL11B |
B-cell CLL/lymphoma 11B (zinc finger protein) |
chr6_+_125540951 | 0.64 |
ENST00000524679.1 |
TPD52L1 |
tumor protein D52-like 1 |
chr2_+_33359687 | 0.64 |
ENST00000402934.1 ENST00000404525.1 ENST00000407925.1 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
chr8_-_13372253 | 0.64 |
ENST00000316609.5 |
DLC1 |
deleted in liver cancer 1 |
chr9_+_71819927 | 0.63 |
ENST00000535702.1 |
TJP2 |
tight junction protein 2 |
chr19_+_39138271 | 0.63 |
ENST00000252699.2 |
ACTN4 |
actinin, alpha 4 |
chr14_-_21270995 | 0.63 |
ENST00000555698.1 ENST00000397970.4 ENST00000340900.3 |
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic) |
chr11_-_8832182 | 0.63 |
ENST00000527510.1 ENST00000528527.1 ENST00000528523.1 ENST00000313726.6 |
ST5 |
suppression of tumorigenicity 5 |
chr1_+_36621529 | 0.62 |
ENST00000316156.4 |
MAP7D1 |
MAP7 domain containing 1 |
chr1_-_154943212 | 0.62 |
ENST00000368445.5 ENST00000448116.2 ENST00000368449.4 |
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
chr20_-_10654639 | 0.62 |
ENST00000254958.5 |
JAG1 |
jagged 1 |
chr13_-_72440901 | 0.62 |
ENST00000359684.2 |
DACH1 |
dachshund homolog 1 (Drosophila) |
chr1_-_169337176 | 0.59 |
ENST00000472647.1 ENST00000367811.3 |
NME7 |
NME/NM23 family member 7 |
chr8_+_104831472 | 0.59 |
ENST00000262231.10 ENST00000507740.1 |
RIMS2 |
regulating synaptic membrane exocytosis 2 |
chrX_+_73641286 | 0.58 |
ENST00000587091.1 |
SLC16A2 |
solute carrier family 16, member 2 (thyroid hormone transporter) |
chr14_-_99737822 | 0.58 |
ENST00000345514.2 ENST00000443726.2 |
BCL11B |
B-cell CLL/lymphoma 11B (zinc finger protein) |
chr2_+_234601512 | 0.57 |
ENST00000305139.6 |
UGT1A6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
chrX_-_100662881 | 0.57 |
ENST00000218516.3 |
GLA |
galactosidase, alpha |
chr11_-_65667884 | 0.57 |
ENST00000448083.2 ENST00000531493.1 ENST00000532401.1 |
FOSL1 |
FOS-like antigen 1 |
chr1_+_157963063 | 0.56 |
ENST00000360089.4 ENST00000368173.3 ENST00000392272.2 |
KIRREL |
kin of IRRE like (Drosophila) |
chr3_+_118892362 | 0.56 |
ENST00000497685.1 ENST00000264234.3 |
UPK1B |
uroplakin 1B |
chrX_+_16964794 | 0.56 |
ENST00000357277.3 |
REPS2 |
RALBP1 associated Eps domain containing 2 |
chr7_-_27142290 | 0.55 |
ENST00000222718.5 |
HOXA2 |
homeobox A2 |
chr8_+_11666649 | 0.55 |
ENST00000528643.1 ENST00000525777.1 |
FDFT1 |
farnesyl-diphosphate farnesyltransferase 1 |
chr12_-_15038779 | 0.55 |
ENST00000228938.5 ENST00000539261.1 |
MGP |
matrix Gla protein |
chr7_-_151511911 | 0.54 |
ENST00000392801.2 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr11_+_20044600 | 0.54 |
ENST00000311043.8 |
NAV2 |
neuron navigator 2 |
chr11_-_66056596 | 0.54 |
ENST00000471387.2 ENST00000359461.6 ENST00000376901.4 |
YIF1A |
Yip1 interacting factor homolog A (S. cerevisiae) |
chr8_-_13134045 | 0.53 |
ENST00000512044.2 |
DLC1 |
deleted in liver cancer 1 |
chr8_+_22438009 | 0.53 |
ENST00000409417.1 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr14_-_54423529 | 0.53 |
ENST00000245451.4 ENST00000559087.1 |
BMP4 |
bone morphogenetic protein 4 |
chr6_+_25279651 | 0.53 |
ENST00000329474.6 |
LRRC16A |
leucine rich repeat containing 16A |
chr1_+_169077172 | 0.52 |
ENST00000499679.3 |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr2_-_55277436 | 0.51 |
ENST00000354474.6 |
RTN4 |
reticulon 4 |
chr12_-_53343602 | 0.51 |
ENST00000546897.1 ENST00000552551.1 |
KRT8 |
keratin 8 |
chr11_+_27062272 | 0.50 |
ENST00000529202.1 ENST00000533566.1 |
BBOX1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr2_-_190044480 | 0.50 |
ENST00000374866.3 |
COL5A2 |
collagen, type V, alpha 2 |
chrX_+_102840408 | 0.50 |
ENST00000468024.1 ENST00000472484.1 ENST00000415568.2 ENST00000490644.1 ENST00000459722.1 ENST00000472745.1 ENST00000494801.1 ENST00000434216.2 ENST00000425011.1 |
TCEAL4 |
transcription elongation factor A (SII)-like 4 |
chr3_+_111717511 | 0.50 |
ENST00000478951.1 ENST00000393917.2 |
TAGLN3 |
transgelin 3 |
chr9_-_35691017 | 0.48 |
ENST00000378292.3 |
TPM2 |
tropomyosin 2 (beta) |
chr16_-_89785777 | 0.48 |
ENST00000561976.1 |
VPS9D1 |
VPS9 domain containing 1 |
chr2_+_33359646 | 0.48 |
ENST00000390003.4 ENST00000418533.2 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
chr1_+_154193325 | 0.48 |
ENST00000428931.1 ENST00000441890.1 ENST00000271877.7 ENST00000412596.1 ENST00000368504.1 ENST00000437652.1 |
UBAP2L |
ubiquitin associated protein 2-like |
chr8_-_6420930 | 0.47 |
ENST00000325203.5 |
ANGPT2 |
angiopoietin 2 |
chr4_-_70626314 | 0.47 |
ENST00000510821.1 |
SULT1B1 |
sulfotransferase family, cytosolic, 1B, member 1 |
chr12_-_7125770 | 0.47 |
ENST00000261407.4 |
LPCAT3 |
lysophosphatidylcholine acyltransferase 3 |
chr1_+_2036149 | 0.46 |
ENST00000482686.1 ENST00000400920.1 ENST00000486681.1 |
PRKCZ |
protein kinase C, zeta |
chr5_+_140749803 | 0.46 |
ENST00000576222.1 |
PCDHGB3 |
protocadherin gamma subfamily B, 3 |
chr20_-_23066953 | 0.46 |
ENST00000246006.4 |
CD93 |
CD93 molecule |
chr2_-_55277512 | 0.46 |
ENST00000402434.2 |
RTN4 |
reticulon 4 |
chr13_-_29069232 | 0.46 |
ENST00000282397.4 ENST00000541932.1 ENST00000539099.1 |
FLT1 |
fms-related tyrosine kinase 1 |
chr14_-_45431091 | 0.46 |
ENST00000579157.1 ENST00000396128.4 ENST00000556500.1 |
KLHL28 |
kelch-like family member 28 |
chr15_-_88799948 | 0.46 |
ENST00000394480.2 |
NTRK3 |
neurotrophic tyrosine kinase, receptor, type 3 |
chr16_+_57653989 | 0.45 |
ENST00000567835.1 ENST00000569372.1 ENST00000563548.1 ENST00000562003.1 |
GPR56 |
G protein-coupled receptor 56 |
chr11_-_104972158 | 0.45 |
ENST00000598974.1 ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1 CARD16 CARD17 |
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr11_+_35211429 | 0.45 |
ENST00000525688.1 ENST00000278385.6 ENST00000533222.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr16_-_79634595 | 0.44 |
ENST00000326043.4 ENST00000393350.1 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr8_-_6420565 | 0.44 |
ENST00000338312.6 |
ANGPT2 |
angiopoietin 2 |
chr10_+_71561630 | 0.44 |
ENST00000398974.3 ENST00000398971.3 ENST00000398968.3 ENST00000398966.3 ENST00000398964.3 ENST00000398969.3 ENST00000356340.3 ENST00000398972.3 ENST00000398973.3 |
COL13A1 |
collagen, type XIII, alpha 1 |
chr10_+_71561649 | 0.44 |
ENST00000398978.3 ENST00000354547.3 ENST00000357811.3 |
COL13A1 |
collagen, type XIII, alpha 1 |
chr18_+_19749386 | 0.44 |
ENST00000269216.3 |
GATA6 |
GATA binding protein 6 |
chrX_-_152989798 | 0.44 |
ENST00000441714.1 ENST00000442093.1 ENST00000429550.1 ENST00000345046.6 |
BCAP31 |
B-cell receptor-associated protein 31 |
chr19_+_35645618 | 0.43 |
ENST00000392218.2 ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5 |
FXYD domain containing ion transport regulator 5 |
chr1_-_27481401 | 0.43 |
ENST00000263980.3 |
SLC9A1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
chr2_+_101436564 | 0.43 |
ENST00000335681.5 |
NPAS2 |
neuronal PAS domain protein 2 |
chr10_-_29811456 | 0.43 |
ENST00000535393.1 |
SVIL |
supervillin |
chr6_-_111888474 | 0.42 |
ENST00000368735.1 |
TRAF3IP2 |
TRAF3 interacting protein 2 |
chr11_+_114168773 | 0.42 |
ENST00000542647.1 ENST00000545255.1 |
NNMT |
nicotinamide N-methyltransferase |
chr10_+_1102721 | 0.41 |
ENST00000263150.4 |
WDR37 |
WD repeat domain 37 |
chr2_+_90108504 | 0.41 |
ENST00000390271.2 |
IGKV6D-41 |
immunoglobulin kappa variable 6D-41 (non-functional) |
chr2_+_45168875 | 0.41 |
ENST00000260653.3 |
SIX3 |
SIX homeobox 3 |
chr2_-_188312971 | 0.41 |
ENST00000410068.1 ENST00000447403.1 ENST00000410102.1 |
CALCRL |
calcitonin receptor-like |
chr12_-_71031185 | 0.41 |
ENST00000548122.1 ENST00000551525.1 ENST00000550358.1 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
chr2_+_102608306 | 0.40 |
ENST00000332549.3 |
IL1R2 |
interleukin 1 receptor, type II |
chrX_-_24665208 | 0.40 |
ENST00000356768.4 |
PCYT1B |
phosphate cytidylyltransferase 1, choline, beta |
chr2_+_11864458 | 0.40 |
ENST00000396098.1 ENST00000396099.1 ENST00000425416.2 |
LPIN1 |
lipin 1 |
chr13_-_99630233 | 0.39 |
ENST00000376460.1 ENST00000442173.1 |
DOCK9 |
dedicator of cytokinesis 9 |
chr13_+_78109804 | 0.39 |
ENST00000535157.1 |
SCEL |
sciellin |
chr2_+_210288760 | 0.39 |
ENST00000199940.6 |
MAP2 |
microtubule-associated protein 2 |
chr11_+_57529234 | 0.39 |
ENST00000360682.6 ENST00000361796.4 ENST00000529526.1 ENST00000426142.2 ENST00000399050.4 ENST00000361391.6 ENST00000361332.4 ENST00000532463.1 ENST00000529986.1 ENST00000358694.6 ENST00000532787.1 ENST00000533667.1 ENST00000532649.1 ENST00000528621.1 ENST00000530748.1 ENST00000428599.2 ENST00000527467.1 ENST00000528232.1 ENST00000531014.1 ENST00000526772.1 ENST00000529873.1 ENST00000525902.1 ENST00000532844.1 ENST00000526357.1 ENST00000530094.1 ENST00000415361.2 ENST00000532245.1 ENST00000534579.1 ENST00000526938.1 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
chr11_+_35211511 | 0.39 |
ENST00000524922.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr3_+_111717600 | 0.38 |
ENST00000273368.4 |
TAGLN3 |
transgelin 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 1.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 3.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 6.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 1.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 2.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 2.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 3.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 1.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 5.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 2.8 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.4 | 4.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.7 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.4 | 1.9 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 1.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 2.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 3.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.3 | 0.8 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.7 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 3.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 2.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.8 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.2 | 1.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 1.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.2 | 0.7 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.2 | 1.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.5 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 6.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 2.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 2.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 1.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 1.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.6 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 3.4 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.7 | GO:0070700 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) BMP receptor binding(GO:0070700) |
0.0 | 1.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.0 | 1.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 1.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 1.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 9.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 2.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 1.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 4.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.2 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.0 | 0.2 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 1.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.3 | GO:0016411 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) acylglycerol O-acyltransferase activity(GO:0016411) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 1.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.0 | 0.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.0 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.0 | 0.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.0 | 0.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.0 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.0 | 0.5 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 9.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 6.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 3.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 4.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 2.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 2.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 2.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 2.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.8 | PID P73PATHWAY | p73 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.2 | 7.5 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.9 | 2.8 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.9 | 2.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 1.9 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.6 | 1.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.6 | 1.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.6 | 1.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.5 | 3.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 1.9 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.5 | 3.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.4 | 1.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.4 | 1.3 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
0.4 | 1.1 | GO:0021558 | midbrain-hindbrain boundary morphogenesis(GO:0021555) trochlear nerve development(GO:0021558) |
0.3 | 1.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 1.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 1.0 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 1.6 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
0.3 | 1.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 2.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 1.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 1.8 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.3 | 1.1 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.3 | 0.8 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.3 | 0.8 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 1.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.8 | GO:2000795 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 2.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.7 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.2 | 1.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.2 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.2 | 0.7 | GO:0098904 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) regulation of AV node cell action potential(GO:0098904) regulation of bundle of His cell action potential(GO:0098905) |
0.2 | 0.9 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.2 | 0.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 1.9 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 6.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 0.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 1.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.2 | 1.0 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.2 | 1.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.6 | GO:0021569 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 1.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.9 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.2 | 0.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 0.9 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 0.7 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.2 | 3.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.8 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.2 | 0.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 0.8 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.2 | 4.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 0.5 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 1.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.4 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 1.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 1.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 1.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.4 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 1.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.5 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.5 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.8 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 1.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 1.4 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 0.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.1 | 0.9 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.4 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.1 | 0.8 | GO:1904753 | positive regulation of heart rate by epinephrine(GO:0003065) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.1 | 0.3 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 1.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.8 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.7 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.3 | GO:0035441 | bundle of His development(GO:0003166) cardiac left ventricle formation(GO:0003218) cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.4 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.4 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.4 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 0.8 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.1 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.1 | 0.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.3 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.4 | GO:1902847 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 3.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.2 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.1 | 0.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 2.2 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.1 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.3 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 1.6 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.7 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.2 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.0 | 0.3 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.0 | 0.1 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.0 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 5.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0097477 | oviduct development(GO:0060066) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) positive regulation of gastrulation(GO:2000543) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.0 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.0 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.2 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.0 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.4 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.2 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.0 | 0.2 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.0 | 0.8 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.8 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.0 | 0.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.5 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.1 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.0 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.2 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:1903047 | mitotic cell cycle process(GO:1903047) |
0.0 | 0.3 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 3.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.2 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.0 | 0.2 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.5 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.0 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.4 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 1.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.4 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.6 | GO:0030855 | epithelial cell differentiation(GO:0030855) |
0.0 | 0.0 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 1.2 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.1 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.4 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 1.2 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.0 | 0.2 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.0 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.1 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.3 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.5 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.4 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.0 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.0 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.5 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
1.0 | 7.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 3.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 1.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.3 | 1.7 | GO:0031905 | early endosome lumen(GO:0031905) |
0.3 | 1.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.3 | 1.3 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.3 | 1.2 | GO:0031673 | H zone(GO:0031673) |
0.3 | 0.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 1.3 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.3 | 2.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 1.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 1.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 1.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 1.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 4.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 2.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.1 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 2.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.8 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 2.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.8 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 3.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 2.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 2.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.1 | 2.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.0 | 0.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 2.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 1.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 2.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.0 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 4.5 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 1.1 | GO:0005769 | early endosome(GO:0005769) |